Home / News / Alphabet and GSK in Bioelectronics

Alphabet and GSK in Bioelectronics

Google partnent company Alphabet and UK farmaceutical company GlaxoSmithKline (GSK) are joining in a joint ventrue to invest 715 million US dollars in bioelectronics according to Reuters.

GSK is participating for 55% and the Verili Life Sciences on behalf of Alphabet gets 45%. The total investments are spread over seven years. The new Galvani Bioelectronics is planning to develop medical treatments using a small implant that stimulates physical reactions in the body with electrical impulses. These methods are according to Galvani going to help treat chronic diseases like; asthma, diabetes and arthritis.

Related articles:



Check Also


AT&T in Cuba

Telecomprovider AT&T joins with the Cuban state-owned telecom provider to provide roaming services in Cuba. With this new …

Leave a Reply

Your email address will not be published. Required fields are marked *